{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:06:26Z","timestamp":1788170786882,"version":"build-2803163510"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006162","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Ci\u00eancia e Tecnologia do Estado de Pernambuco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-25539-2","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T12:57:05Z","timestamp":1764593825000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond DALY: public funding of health innovation in Brazil as a political strategy for equity in the Global South"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0356-8083","authenticated-orcid":false,"given":"Jabson Herber Profiro","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-4748","authenticated-orcid":false,"given":"Igor Eduardo Silva","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6535-5556","authenticated-orcid":false,"given":"Manoel Raimundo","family":"de Sena J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0181-7624","authenticated-orcid":false,"given":"F\u00e1bio Henrique Cavalcanti","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4873-915X","authenticated-orcid":false,"given":"Monica Felts","family":"de La Roca Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9148-8819","authenticated-orcid":false,"given":"Carlos Augusto Grabois","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3280-0294","authenticated-orcid":false,"given":"Jos\u00e9 Lamartine Soares","family":"Sobrinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"25539_CR1","unstructured":"WORLD HEALTH ORGANIZATION (WHO). Tackling neglected tropical diseases with water sanitation and hygiene [Internet]. 2019 [cited 2022 Jan 18]; Available from: https:\/\/www.who.int\/news-room\/facts-in-pictures\/detail\/tackling-neglected-tropical-diseases-with-water-sanitation-and-hygiene"},{"key":"25539_CR2","unstructured":"WORLD HEALTH ORGANIZATION (WHO). Global report on neglected tropical diseases 2023 [Internet]. Geneva (Switzerland): 2023. Available from: https:\/\/www.who.int\/teams\/control-of-neglected-tropical-diseases\/global-report-on-neglected-tropical-diseases-2023"},{"key":"25539_CR3","unstructured":"WORLD HEALTH ORGANIZATION (WHO). Neglected tropical diseases: treating more than one billion people for the fifth consecutive year [Internet]. 2020 [cited 2023 Jan 30]; Available from: https:\/\/www.who.int\/news\/item\/16-07-2020-neglected-tropical-diseases-treating-more-than-one-billion-people-for-the-fifth-consecutive-year"},{"issue":"10100","key":"25539_CR4","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(17)32130-X","volume":"390","author":"SI Hay","year":"2017","unstructured":"Hay SI, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1260\u2013344.\u00a0https:\/\/doi.org\/10.1016\/S0140-6736(17)32130-X.","journal-title":"Lancet"},{"issue":"10258","key":"25539_CR5","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.\u00a0https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9.","journal-title":"Lancet"},{"key":"25539_CR6","doi-asserted-by":"publisher","unstructured":"Kuper H. Neglected tropical diseases and disability\u2014what is the link? Trans. R. Soc. Trop. Med. Hyg. 2019;113(12):839\u201344. https:\/\/doi.org\/10.1093\/trstmh\/trz001 class=\"oxedel_1\" id=\"oxe_del_1_1762650128529_8105092129157604\" user=\"Jabson Herber Profiro de Oliveira\" deletedat=\"11-08-2025 22:02:08\">\"","DOI":"10.1093\/trstmh\/trz001"},{"key":"25539_CR7","doi-asserted-by":"publisher","unstructured":"Kuper H. Disability, mental health, stigma and discrimination and neglected tropical diseases. Trans. R. Soc. Trop. Med. Hyg. 2021;115(2):145\u20136. https:\/\/doi.org\/10.1093\/trstmh\/traa160","DOI":"10.1093\/trstmh\/traa160"},{"key":"25539_CR8","doi-asserted-by":"publisher","unstructured":"Hamill LC, Haslam D, Abrahamsson S, Hill B, Dixon R, Burgess H, et al. People are neglected, not diseases: the relationship between disability and neglected tropical diseases. Trans R Soc Trop Med Hyg. 2019;113(12):829\u201334.\u00a0https:\/\/doi.org\/10.1093\/trstmh\/trz036.","DOI":"10.1093\/trstmh\/trz036"},{"key":"25539_CR9","doi-asserted-by":"publisher","unstructured":"Litt E, Baker MC, Molyneux D. Neglected tropical diseases and mental health: a perspective on comorbidity. Trends Parasitol. 2012;28(5):195\u2013201.\u00a0https:\/\/doi.org\/10.1016\/j.pt.2012.03.001.","DOI":"10.1016\/j.pt.2012.03.001"},{"key":"25539_CR10","unstructured":"World Health Organization (WHO). Neglected tropical diseases, World Health Data Platform [Internet]. 2021 [cited 2021 Nov 17]; Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/neglected-tropical-diseases"},{"key":"25539_CR11","doi-asserted-by":"publisher","unstructured":"Jacob JT, Franco-Paredes C. The stigmatization of leprosy in India and its impact on future approaches to elimination and control. PLoS Negl Trop Dis. 2008;2(1):e113. https:\/\/doi.org\/10.1371\/journal.pntd.0000113.","DOI":"10.1371\/journal.pntd.0000113"},{"issue":"1","key":"25539_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-017-0379-y","volume":"6","author":"JM Kirigia","year":"2017","unstructured":"Kirigia JM, Mburugu GN. The monetary value of human lives lost due to neglected tropical diseases in Africa. Infect Dis Poverty. 2017;6(1):165. https:\/\/doi.org\/10.1186\/s40249-017-0379-y.","journal-title":"Infect Dis Poverty"},{"key":"25539_CR13","doi-asserted-by":"publisher","unstructured":"Babu B, Nayak A, Dhal K, Acharya A, Jangid P, Mallick G. The economic loss due to treatment costs and work loss to individuals with chronic lymphatic filariasis in rural communities of Orissa, India. Acta Trop. . 2002;82(1):31\u20138.\u00a0https:\/\/doi.org\/10.1016\/S0001-706X(02)00030-X.","DOI":"10.1016\/S0001-706X(02)00030-X"},{"issue":"9","key":"25539_CR14","doi-asserted-by":"publisher","first-page":"e0004042","DOI":"10.1371\/journal.pntd.0004042","volume":"9","author":"CMT Martelli","year":"2015","unstructured":"Martelli CMT, Siqueira JB, Parente MPPD, Zara AL, de Oliveira SA, Braga CS. Economic impact of dengue: multicenter study across four Brazilian regions. PLoS Negl Trop Dis. 2015;9(9):e0004042.\u00a0https:\/\/doi.org\/10.1371\/journal.pntd.0004042.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"25539_CR15","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ijcard.2013.01.262","volume":"168","author":"A Abuhab","year":"2013","unstructured":"Abuhab A, Trindade E, Aulicino GB, Fujii S, Bocchi EA, Bacal F. Chagas\u2019 cardiomyopathy: the economic burden of an expensive and neglected disease. Int J Cardiol. 2013;168(3):2375\u201380.\u00a0https:\/\/doi.org\/10.1016\/j.ijcard.2013.01.262.","journal-title":"Int J Cardiol"},{"key":"25539_CR16","unstructured":"World Health Organization (WHO). Global report on neglected tropical diseases 2023 - Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021\u2009\u2013\u2009203 [Internet]. Switzerland. 2023. Available from: https:\/\/www.who.int\/teams\/control-of-neglected-tropical-diseases\/global-report-on-neglected-tropical-diseases-2023"},{"key":"25539_CR17","unstructured":"Institute for Health Metrics and Evaluation. Global Health Data Exchange [Internet]. 2025 [cited 2024 Mar 13]; Available from: http:\/\/ghdx.healthdata.org\/"},{"key":"25539_CR18","first-page":"1","volume":"2","author":"CMMRT Morel","year":"2006","unstructured":"Morel CMMRT. A global health innovation system (GHIS). Glob Forum Updat Res Heal Combat Dis Promot Heal. 2006;2:1\u201312. ISBN:2940286442.","journal-title":"Glob Forum Updat Res Heal Combat Dis Promot Heal"},{"key":"25539_CR19","unstructured":"WORLD HEALTH ORGANIZATION (WHO). Adhoc Committee (of the WHO) on health research relating to future intervention options. Investing in health research and development. World Health Organization. Geneva(Switzerland): 1996."},{"key":"25539_CR20","doi-asserted-by":"publisher","unstructured":"Costa DM, Magalh\u00e3es R. Realismo cr\u00edtico e desigualdades sociais: considera\u00e7\u00f5es a partir de uma pesquisa avaliativa. Cien. Saude Colet. 2020;25(5):1779\u201388. https:\/\/doi.org\/10.1590\/1413-81232020255.33352019","DOI":"10.1590\/1413-81232020255.33352019"},{"issue":"4","key":"25539_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/jac\/dkx516","volume":"73","author":"E Aldasoro","year":"2018","unstructured":"Aldasoro E, Posada E, Requena-M\u00e9ndez A, Calvo-Cano A, Serret N, Casellas A, et al. What to expect and when: benznidazole toxicity in chronic chagas\u2019 disease treatment. J Antimicrob Chemother. 2018;73(4):1060\u20137.\u00a0https:\/\/doi.org\/10.1093\/jac\/dkx516.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"25539_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1191\/0960327106het653oa","volume":"25","author":"JA Castro","year":"2006","unstructured":"Castro JA, deMecca MM, Bartel LC. Toxic side effects of drugs used to treat Chagas\u2019 disease (American trypanosomiasis). Hum Exp Toxicol. 2006;25(8):471\u20139. https:\/\/doi.org\/10.1191\/0960327106het653oa.","journal-title":"Hum Exp Toxicol"},{"issue":"3","key":"25539_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1023\/A:1016212804288","volume":"12","author":"GL Amidon","year":"1995","unstructured":"Amidon GL, Lennern\u00e4s H, Shah VP. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12(3):413\u201320.\u00a0https:\/\/doi.org\/10.1023\/A:1016212804288.","journal-title":"Pharm Res"},{"key":"25539_CR24","doi-asserted-by":"publisher","unstructured":"Hong S-J, Kim Y-M. Encapsulation of Clofazimine by Cyclodextran: Preparation, Characterization, and In Vitro Release Properties. Int. J. Mol. Sci. 2023;24(10):8808. https:\/\/doi.org\/10.3390\/ijms24108808.","DOI":"10.3390\/ijms24108808"},{"key":"25539_CR25","doi-asserted-by":"publisher","unstructured":"Salem I. Efficacy of clofazimine\u2013modified cyclodextrin against Mycobacterium avium complex in human macrophages. Int. J. Pharm. 2003;260(1):105\u201314. https:\/\/doi.org\/10.1016\/S0378-5173(03)00236-9\"","DOI":"10.1016\/S0378-5173(03)00236-9"},{"key":"25539_CR26","doi-asserted-by":"publisher","unstructured":"Shamma RN, Salah Ad-din I, Abdeltawab NF. Dapsone- gel as a novel platform for acne treatment: In vitro evaluation and In vivo performance and histopathological studies in acne infected mice. J. Drug Deliv. Sci. Technol. 2019;54:101238. https:\/\/doi.org\/10.1016\/j.jddst.2019.101238.","DOI":"10.1016\/j.jddst.2019.101238"},{"key":"25539_CR27","doi-asserted-by":"publisher","unstructured":"Swain SS, Paidesetty SK, Dehury B, Das M, Vedithi SC, Padhy RN. Computer-aided synthesis of dapsone-phytochemical conjugates against dapsone-resistant Mycobacterium leprae. Sci. Rep. 2020;10(1):6839.\u00a0https:\/\/doi.org\/10.1038\/s41598-020-63913-9.","DOI":"10.1038\/s41598-020-63913-9"},{"key":"25539_CR28","doi-asserted-by":"publisher","unstructured":"Dados N, Connell R. The Global South. Contexts . 2012;11(1):12\u20133.\u00a0https:\/\/doi.org\/10.1177\/1536504212436479.","DOI":"10.1177\/1536504212436479"},{"key":"25539_CR29","doi-asserted-by":"publisher","unstructured":"Roberti J, Leslie HH, Doubova SV, Ranilla JM, Mazzoni A, Espinoza L et al. Inequalities in health system coverage and quality: a cross-sectional survey of four Latin American countries. Lancet Glob. Heal. 2024;12(1):e145\u201355.\u00a0https:\/\/doi.org\/10.1016\/S2214-109X(23)00488-6.","DOI":"10.1016\/S2214-109X(23)00488-6"},{"key":"25539_CR30","doi-asserted-by":"publisher","unstructured":"Peres IT, Braga L, da Bastos C, SL L, Villalobos-Cid M. Efficiency Analysis of Healthcare Systems in Latin American and Caribbean Countries: An Application Based on Data Envelopment Analysis. Value Heal. Reg. Issues. 2025;46:101075.\u00a0https:\/\/doi.org\/10.1016\/j.vhri.2024.101075.","DOI":"10.1016\/j.vhri.2024.101075"},{"key":"25539_CR31","unstructured":"NU. CEPAL, PAHO; WHO. The urgency of investing in health systems in Latin America and the Caribbean to reduce inequality and achieve the Sustainable Development Goals. ECLAC; PAHO; WHO. . 2024. Available from: https:\/\/www.cepal.org\/en\/publications\/80764-urgency-investing-health-systems-latin-america-and-caribbean-reduce-inequality"},{"key":"25539_CR32","doi-asserted-by":"publisher","unstructured":"Barreto ML. Desigualdades em Sa\u00fade: uma perspectiva global. Cien. Saude Colet. . 2017;22(7):2097\u2013108. https:\/\/doi.org\/10.1590\/1413-81232017227.02742017.","DOI":"10.1590\/1413-81232017227.02742017"},{"key":"25539_CR33","unstructured":"World Health Organization, Global Health A. Strategy 2025\u20132028, advancing equity and resilience in a turbulent world [Internet]. Geneva (Sswitzerland): 2025. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240101012"},{"key":"25539_CR34","doi-asserted-by":"publisher","unstructured":"Gadelha CAG. Complexo Econ\u00f4mico-Industrial da Sa\u00fade: a base econ\u00f4mica e material do Sistema \u00danico de Sa\u00fade. Cad. Saude Publica . 2022;38(suppl 2).\u00a0https:\/\/doi.org\/10.1590\/0102-311X00263321.","DOI":"10.1590\/0102-311X00263321"},{"key":"25539_CR35","doi-asserted-by":"publisher","unstructured":"Petersen OH. Inequality of Research Funding between Different Countries and Regions is a Serious Problem for Global Science. Function . 2021;2(6).\u00a0https:\/\/doi.org\/10.1093\/function\/zqab060\/6423772.","DOI":"10.1093\/function\/zqab060\/6423772"},{"key":"25539_CR36","doi-asserted-by":"publisher","unstructured":"Cleary EG, Beierlein JM, Khanuja NS, McNamee LM, Ledley FD. Contribution of NIH funding to new drug approvals 2010\u20132016. Proc. Natl. Acad. Sci. U. S. A. 2018;115(10):2329\u201334.\u00a0https:\/\/doi.org\/10.1073\/pnas.1715368115.","DOI":"10.1073\/pnas.1715368115"},{"issue":"6","key":"25539_CR37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1056\/NEJMsa1008268","volume":"364","author":"AJ Stevens","year":"2011","unstructured":"Stevens AJ, Jensen JJ, Wyller K, Kilgore PC, Chatterjee S, Rohrbaugh ML. The role of public-sector research in the discovery of drugs and vaccines. N Engl J Med. 2011;364(6):535\u201341. https:\/\/doi.org\/10.1056\/NEJMsa1008268.","journal-title":"N Engl J Med"},{"key":"25539_CR38","doi-asserted-by":"publisher","unstructured":"Gadelha CAG, Braga PS. da C. Health and innovation: economic dynamics and Welfare State in Brazil. Cad. Saude Publica 2016;32(suppl 2).\u00a0https:\/\/doi.org\/10.1590\/0102-311X00150115.","DOI":"10.1590\/0102-311X00150115"},{"key":"25539_CR39","unstructured":"Mazzucato MO. Estado empreendedor: Desmascarando o Mito do setor p\u00fablico x setor privado. 1a. Portfolio-Penguin. S\u00e3o Paulo (SP). 2014."},{"key":"25539_CR40","doi-asserted-by":"publisher","unstructured":"Zhou EW, Jackson MJ, Ledley FD, Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry. JAMA Heal. Forum . 2023;4(7):e231921.\u00a0https:\/\/doi.org\/10.1001\/jamahealthforum.2023.1921.","DOI":"10.1001\/jamahealthforum.2023.1921"},{"key":"25539_CR41","unstructured":"de Negri FF. HSS. Sistemas Setoriais de Inova\u00e7\u00e3o e Infraestrutura de Pesquisa no Brasil [Internet]. Bras\u00edlia (Brasil): IPEA (Instituto de Pesquisas Econ\u00f4micas Aplicadas); 2016. Available from: https:\/\/ipea.gov.br\/portal\/index.php?option=com_content&id=27203:sistemas-setoriais-de-inovacao-e-infraestrutura-de-pesquisa-no-brasil"},{"key":"25539_CR42","doi-asserted-by":"publisher","unstructured":"Mazzucato M. 6. Innovation, the State and Patient Capital. Polit. Q. 2015;86(May) :98\u2013118. https:\/\/doi.org\/10.1111\/1467-923X.12235","DOI":"10.1111\/1467-923X.12235"},{"key":"25539_CR43","unstructured":"CGEE. Panorama da ci\u00eancia Brasileira: 2015\u20132020. Brasilia\/DF(Brasil): CGEE (Centro de Gest\u00e3o e Estudos Estrat\u00e9gicos); 2021."},{"key":"25539_CR44","doi-asserted-by":"publisher","unstructured":"Dujardin JC, Herrera S, do Rosario V, Arevalo J, Boelaert M, Carrasco HJ, et al. Research priorities for neglected infectious diseases in Latin America and the Caribbean region. PLoS Negl Trop Dis. 2010. https:\/\/doi.org\/10.1371\/journal.pntd.0000780.","DOI":"10.1371\/journal.pntd.0000780"},{"key":"25539_CR45","unstructured":"G-Finder. Neglected disease research and development: the higher cost of lower funding [Internet]. Australia: 2023. Available from: https:\/\/www.policycuresresearch.org"},{"issue":"2","key":"25539_CR46","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1590\/S1413-81232004000200014","volume":"9","author":"R Guimar\u00e3es","year":"2004","unstructured":"Guimar\u00e3es R. Bases Para Uma pol\u00edtica Nacional de ci\u00eancia, tecnologia e inova\u00e7\u00e3o Em sa\u00fade. Cien Saude Colet. 2004;9(2):375\u201387.\u00a0https:\/\/doi.org\/10.1590\/S1413-81232004000200014.","journal-title":"Cien Saude Colet"},{"key":"25539_CR47","unstructured":"BRASIL. Minist\u00e9rio da Sa\u00fade. Pol\u00edtica Nacional de Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o em Sa\u00fade. 2a edi\u00e7\u00e3o,. Bras\u00edlia (DF). 2008: Textos B\u00e1sicos em Sa\u00fade; 2008."},{"issue":"spe3","key":"25539_CR48","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1590\/0103-11042017s307","volume":"41","author":"LM Vieira-da-Silva","year":"2017","unstructured":"Vieira-da-Silva LM, Silva GAP, da, Esperidi\u00e3o MA. Avalia\u00e7\u00e3o Da implanta\u00e7\u00e3o Da Pol\u00edtica Nacional de Ci\u00eancia, tecnologia e Inova\u00e7\u00e3o Em Sa\u00fade no Brasil. Sa\u00fade Em Debate. 2017;41(spe3):87\u201398.","journal-title":"Sa\u00fade Em Debate"},{"key":"25539_CR49","unstructured":"BRASIL. Minist\u00e9rio da Sa\u00fade. Agenda Nacional de Prioridades de Pesquisa em Sa\u00fade. Minist\u00e9rio da Sa\u00fade. Bras\u00edlia\/DF (Brasil): 2006."},{"key":"25539_CR50","volume-title":"Sele\u00e7\u00e3o de prioridades de pesquisa Em sa\u00fade: Guia PPSUS","author":"BRASIL","year":"2008","unstructured":"BRASIL. Sele\u00e7\u00e3o de prioridades de pesquisa Em sa\u00fade: Guia PPSUS. Bras\u00edlia\/DF (Brasil): Minist\u00e9rio da Sa\u00fade; 2008."},{"key":"25539_CR51","unstructured":"BRASIL. Minist\u00e9rio da Sa\u00fade. Agenda de Prioridades de Pesquisa do Minist\u00e9rio da Sa\u00fade (APPMS). Minist\u00e9rio da Sa\u00fade, Secretaria de Ci\u00eancia, Tecnologia e Insumos Estrat\u00e9gicos, Departamento de Ci\u00eancia e Tecnologia. Bras\u00edlia (DF), BRASIL. 2018."},{"key":"25539_CR52","unstructured":"BRASIL M da S. Agenda Nacional de Prioridades de Pesquisa em Sa\u00fade. Minist\u00e9rio da Sa\u00fade. 2a edi\u00e7\u00e3o. Bras\u00edlia\/DF (Brasil). 2015: 2015."},{"key":"25539_CR53","unstructured":"BRASIL MC. Estrat\u00e9gia Nacional de Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o 2016\u20132022, Sum\u00e1rio Executivo. MCTI. Bras\u00edlia\/DF (Brasil): 2018."},{"key":"25539_CR54","unstructured":"BRASIL MC. Plano de A\u00e7\u00e3o em Ci\u00eancia, Tecnologia e Inova\u00e7\u00e3o para Sa\u00fade. MCTI. Bras\u00edlia\/DF (Brasil): 2018."},{"key":"25539_CR55","volume-title":"Alternatives a public policies","author":"J Kingdon","year":"2003","unstructured":"Kingdon J, Agenda. Alternatives a public policies. 3th ed. New York (USA): Harper Collins; 2003.","edition":"3"},{"key":"25539_CR56","doi-asserted-by":"publisher","unstructured":"Morel CM, Serruya SJ, Penna GO, Guimar\u00e3es R. Co-authorship network analysis: a powerful tool for strategic planning of research, development and capacity building programs on neglected diseases. PLoS Negl Trop Dis. 2009. https:\/\/doi.org\/10.1371\/journal.pntd.0000501.","DOI":"10.1371\/journal.pntd.0000501"},{"issue":"2","key":"25539_CR57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/heapol\/11.2.179","volume":"11","author":"C Barker","year":"1996","unstructured":"Barker C, Green A. Opening the debate on DALYs. Health Policy Plan. 1996;11(2):179\u201383. https:\/\/doi.org\/10.1093\/heapol\/11.2.179.","journal-title":"Health Policy Plan"},{"key":"25539_CR58","doi-asserted-by":"publisher","unstructured":"Murray CJL, Acharya AK, Understanding, DALYs. J. Health Econ. 1997;16(6):703\u201330. https:\/\/doi.org\/10.1016\/S0167-6296(97)00004-0","DOI":"10.1016\/S0167-6296(97)00004-0"},{"issue":"2","key":"25539_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016837","volume":"6","author":"LA Gillum","year":"2011","unstructured":"Gillum LA, Gouveia C, Dorsey ER, Pletcher M, Mathers CD, McCulloch CE, et al. NIH disease funding levels and burden of disease. PLoS One. 2011;6(2):e16837.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0016837.","journal-title":"PLoS One"},{"issue":"24","key":"25539_CR60","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1056\/NEJM199906173402406","volume":"340","author":"CP Gross","year":"1999","unstructured":"Gross CP, Anderson GF, Powe NR. The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med. 1999;340(24):1881\u20137.\u00a0https:\/\/doi.org\/10.1056\/NEJM199906173402406.","journal-title":"N Engl J Med"},{"issue":"1suppl","key":"25539_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/1355819613476015","volume":"18","author":"D Ward","year":"2013","unstructured":"Ward D, Martino O, Packer C, Simpson S, Stevens A. Burden of disease, research funding and innovation in the UK: do new health technologies reflect research inputs and need? J Health Serv Res Policy. 2013;18(1suppl):7\u201313.\u00a0https:\/\/doi.org\/10.1177\/1355819613476015.","journal-title":"J Health Serv Res Policy"},{"key":"25539_CR62","unstructured":"BCB. Calculadora do cidad\u00e3o - Banco Central do Brasil [Internet]. 2022 [cited 2022 Dec 7]; Available from: https:\/\/www3.bcb.gov.br\/CALCIDADAO\/publico\/exibirFormCorrecaoValores.do?method=exibirFormCorrecaoValores&aba=1#"},{"issue":"11","key":"25539_CR63","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/tmi.13478","volume":"25","author":"B Fonseca","year":"2020","unstructured":"Fonseca B, de Albuquerque P, Zicker PC. Neglected tropical diseases in brazil: lack of correlation between disease burden, research funding and output. Trop Med Int Heal. 2020;25(11):1373\u201384.\u00a0https:\/\/doi.org\/10.1111\/tmi.13478.","journal-title":"Trop Med Int Heal"},{"issue":"10","key":"25539_CR64","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1016\/S2214-109X(20)30357-0","volume":"8","author":"MG Head","year":"2020","unstructured":"Head MG, Brown RJ, Newell ML, Scott JAG, Batchelor J, Atun R. The allocation of USdollar;105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments. Lancet Glob Heal. 2020;8(10):e1295-304.\u00a0https:\/\/doi.org\/10.1016\/S2214-109X(20)30357-0.","journal-title":"Lancet Glob Heal"},{"issue":"4","key":"25539_CR65","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/heapol\/czg043","volume":"18","author":"DD Reidpath","year":"2003","unstructured":"Reidpath DD. Measuring health in a vacuum: examining the disability weight of the DALY. Health Policy Plan. 2003;18(4):351\u20136. https:\/\/doi.org\/10.1093\/heapol\/czg043.","journal-title":"Health Policy Plan"},{"key":"25539_CR66","unstructured":"Sayers B, McA, Fleider TM. The critique of DALYs: a counter-reply. Bull. World Health Organ. [Internet] 1997;75(4):383\u20134. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2486969\/"},{"key":"25539_CR67","doi-asserted-by":"publisher","unstructured":"Yamey G, Bandara S, Chapman N, Chowdhary V, Doubell A, Hynen A, et al. Analysis of the health product pipeline for poverty-related and neglected diseases using the portfolio-to-impact (P2I) modeling tool. F1000Res. 2020. https:\/\/doi.org\/10.12688\/f1000research.24015.1.","DOI":"10.12688\/f1000research.24015.1"},{"issue":"1","key":"25539_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12961-019-0510-6","volume":"17","author":"YL Jung","year":"2019","unstructured":"Jung YL, Yoo HS, Kim ES. The relationship between government research funding and the cancer burden in South Korea: implications for prioritising health research. Health Res Policy Syst. 2019;17(1): 103. https:\/\/doi.org\/10.1186\/s12961-019-0510-6.","journal-title":"Health Res Policy Syst"},{"key":"25539_CR69","doi-asserted-by":"publisher","unstructured":"Santos J. Resposta brasileira ao controle da tuberculose. Rev. Saude Publica . 2007;41(suppl 1):89\u201393.\u00a0https:\/\/doi.org\/10.1590\/S0034-89102007000800012.","DOI":"10.1590\/S0034-89102007000800012"},{"key":"25539_CR70","unstructured":"BRASIL. MINIST\u00c9RIO DA SA\u00daDE. Programa Nacional de Controle da Hansen\u00edase - PNCH. Bras\u00edlia\/DF (Brasil). 2009."},{"key":"25539_CR71","doi-asserted-by":"publisher","unstructured":"Laplane A, Mazzucato M. Socializing the risks and rewards of public investments: Economic, policy, and legal issues. Res Policy X 2020;2.\u00a0https:\/\/doi.org\/10.1016\/j.repolx.2020.100008.","DOI":"10.1016\/j.repolx.2020.100008"},{"key":"25539_CR72","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tube.2018.09.009","volume":"113","author":"YF van der Heijden","year":"2018","unstructured":"van der Heijden YF, Abdullah F, Andrade BB, Andrews JR, Christopher DJ, Croda J, et al. Building capacity for advances in tuberculosis research; proceedings of the third RePORT international meeting. Tuberculosis. 2018;113:153\u201362. https:\/\/doi.org\/10.1016\/j.tube.2018.09.009.","journal-title":"Tuberculosis"},{"issue":"1","key":"25539_CR73","doi-asserted-by":"publisher","first-page":"1666566","DOI":"10.1080\/16549716.2019.1666566","volume":"12","author":"A Wilder-Smith","year":"2019","unstructured":"Wilder-Smith A, Preet R, Brickley EB, Ximenes RA, de Miranda-Filho A, de Turchi Martelli D. ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas. Glob Health Action. 2019;12(1):1666566. https:\/\/doi.org\/10.1080\/16549716.2019.1666566.","journal-title":"Glob Health Action"},{"key":"25539_CR74","unstructured":"CNPq. Chamada MCTIC, FNDCT-CNPq\/ MEC-CAPES. \/ MS-Decit\/ No 14\/2016 - Preven\u00e7\u00e3o e Combate ao v\u00edrus Zika [Internet]. Chamadas P\u00fablicas2016 [cited 2022 Jan 12]; Available from: http:\/\/memoria2.cnpq.br\/web\/guest\/chamadas-publicas?p_p_id=resultadosportlet_WAR_resultadoscnpqportlet_INSTANCE_0ZaM&id=47-789-4168&detalha=chamadaDetalhada&filtro=encerradas"},{"key":"25539_CR75","unstructured":"OECD TWB. Health at a Glance: Latin America and the Caribbean 2023 [Internet]. Paris, France: OECD. 2023. Available from: https:\/\/www.oecd.org\/en\/publications\/health-at-a-glance-latin-america-and-the-caribbean-2023_532b0e2d-en.html"},{"key":"25539_CR76","unstructured":"NU. CEPAL. Innovaci\u00f3n para el desarrollo: la clave para una recuperaci\u00f3n transformadora en Am\u00e9rica Latina y el Caribe [Internet]. 2021 [cited 2025 Jul 10]; Available from: https:\/\/www.cepal.org\/es\/publicaciones\/47544-innovacion-desarrollo-la-clave-recuperacion-transformadora-america-latina-caribe"},{"key":"25539_CR77","unstructured":"NIH. Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) [Internet]. 2023 [cited 2023 Apr 20];Available from: https:\/\/report.nih.gov\/funding\/categorical-spending#\/"},{"key":"25539_CR78","unstructured":"NIH. NIH RePORT, Research Portfolio Online Reporting Tools [Internet]. 2023 [cited 2023 Apr 20]; Available from: https:\/\/report.nih.gov\/"},{"key":"25539_CR79","doi-asserted-by":"publisher","unstructured":"Profiro de Oliveira JH, Arruda IES, Izak Ribeiro de Ara\u00fajo J, Chaves LL, de La Rocca Soares MF, Soares-Sobrinho JL. Why do few drug delivery systems to combat neglected tropical diseases reach the market? An analysis from the technology\u2019s stages. Expert Opin. Ther. Pat. 2022;32(1):89\u2013114. https:\/\/doi.org\/10.1080\/13543776.2021.1970746","DOI":"10.1080\/13543776.2021.1970746"},{"key":"25539_CR80","doi-asserted-by":"publisher","unstructured":"Lichtenberg FR. The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countries. Econ. Hum. Biol. 2022;46:101124.\u00a0https:\/\/doi.org\/10.1016\/j.ehb.2022.101124.","DOI":"10.1016\/j.ehb.2022.101124"},{"issue":"1","key":"25539_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2202\/1553-3832.1123","volume":"4","author":"TR Lewis","year":"2007","unstructured":"Lewis TR, Reichman JH, So AD. The case for public funding and public oversight of clinical trials. The Economists\u2019 Voice. 2007;4(1):1\u20134. https:\/\/doi.org\/10.2202\/1553-3832.1123.","journal-title":"The Economists' Voice"},{"issue":"5","key":"25539_CR82","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1590\/1413-81232017225.33342016","volume":"22","author":"M Ten\u00f3rio","year":"2017","unstructured":"Ten\u00f3rio M, Mello GA, Viana ALD. A pol\u00edtica de aten\u00e7\u00e3o \u00e0 sa\u00fade do Servidor p\u00fablico federal no brasil: Atores, trajet\u00f3rias e desafios. Cienc Saude Coletiva. 2017;22(5):1441\u201354. https:\/\/doi.org\/10.1590\/1413-81232017225.33542016.","journal-title":"Cienc Saude Coletiva"},{"issue":"1","key":"25539_CR83","doi-asserted-by":"publisher","first-page":"130","DOI":"10.21721\/p2p.2017v4n1.p130-146","volume":"4","author":"M Ten\u00f3rio","year":"2017","unstructured":"Ten\u00f3rio M, Mena-Chalco JP, Mello GA, Viana ALD. Inova\u00e7\u00e3o. Estrutura de pesquisa Em rede: O Caso Da Rede Nacional de pesquisas Cl\u00ednicas Em hospitais de Ensino. P2P E. 2017;4(1):130\u201346. https:\/\/doi.org\/10.21721\/p2p.2017v4n1.p130-146.","journal-title":"P2P E"},{"issue":"2","key":"25539_CR84","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.inhe.2010.04.002","volume":"2","author":"M Moran","year":"2010","unstructured":"Moran M, Guzman J, Ropars AL, Illmer A. The role of product development partnerships in research and development for neglected diseases. Int Health . 2010;2(2):114\u201322. https:\/\/doi.org\/10.1016\/j.inhe.2010.04.002.","journal-title":"Int. Health [Internet]"},{"key":"25539_CR85","unstructured":"OMS (WHO), OPAS B. Fortalecimento da Pol\u00edtica Nacional de Ci\u00eancias, Tecnologia e Inova\u00e7\u00e3o em Sa\u00fade - Relat\u00f3rio T\u00e9cnico 91. OMS\/OPAS\/Minist\u00e9rio da Sa\u00fade do Brasil. 2017."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25539-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25539-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25539-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:54:07Z","timestamp":1767635647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-025-25539-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["25539"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25539-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}